These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35125864)

  • 1. Chromatic Full-Field Stimulus Thresholds in Patients with Treatment-Naive Age-Related Macular Degeneration.
    William A; Dias Blak M; Eshref A; Gekeler F; Schatz A; Gekeler K
    Clin Ophthalmol; 2022; 16():223-229. PubMed ID: 35125864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patients.
    Pedersen KB; Sjølie AK; Møller F
    Acta Ophthalmol; 2009 Nov; 87(7):714-9. PubMed ID: 19094171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choroidal blood flow after the first intravitreal ranibizumab injection in neovascular age-related macular degeneration patients.
    Mottet B; Aptel F; Geiser MH; Hera R; Zhou T; Almanjoumi A; Vinh V; Chiquet C
    Acta Ophthalmol; 2018 Nov; 96(7):e783-e788. PubMed ID: 30203609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early visual impacts of optical coherence tomographic parameters in patients with age-related macular degeneration following the first versus repeated ranibizumab injection.
    Sayed KM; Naito T; Nagasawa T; Katome T; Mitamura Y
    Graefes Arch Clin Exp Ophthalmol; 2011 Oct; 249(10):1449-58. PubMed ID: 21494878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate changes in blood pressure during intravitreal anti-VEGF agents' applications in exudative age-related macular degeneration patients.
    Balci S; Sahin O; Ozcaliskan S; Sevik MO; Mangan MS
    Int Ophthalmol; 2020 Oct; 40(10):2515-2522. PubMed ID: 32495059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Effectiveness of Cataract Surgery with Simultaneous Intravitreal Anti-VEGF in Patients with Previously Treated Exudative Age-Related Macular Degeneration.
    Falcão MS; Freitas-Costa P; Beato JN; Pinheiro-Costa J; Rocha-Sousa A; Carneiro Â; Brandão EM; Falcão-Reis F
    Acta Med Port; 2017 Feb; 30(2):127-133. PubMed ID: 28527480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-Response Relationship between Intravitreal Injections and Retinal Nerve Fiber Layer Thinning in Age-Related Macular Degeneration.
    Wang L; Swaminathan SS; Yang J; Barikian A; Shi Y; Shen M; Jiang X; Feuer W; Gregori G; Rosenfeld PJ
    Ophthalmol Retina; 2021 Jul; 5(7):648-654. PubMed ID: 33045458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Vascular Endothelial Growth Factor Intravitreal Therapy and Macular Ganglion Cell Layer Thickness in Patients with Neovascular Age-Related Macular Degeneration.
    Abdolrahimzadeh S; Gharbiya M; Formisano M; Bertini F; Cerini A; Pacella E
    Curr Eye Res; 2019 Sep; 44(9):1000-1005. PubMed ID: 30999772
    [No Abstract]   [Full Text] [Related]  

  • 9. Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy.
    Horsley MB; Mandava N; Maycotte MA; Kahook MY
    Am J Ophthalmol; 2010 Oct; 150(4):558-561.e1. PubMed ID: 20643396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and Outcomes for Neovascular Age-Related Macular Degeneration: Analysis of United States Electronic Health Records.
    Kiss S; Campbell J; Almony A; Shih V; Serbin M; LaPrise A; Wykoff CC
    Ophthalmology; 2020 Sep; 127(9):1179-1188. PubMed ID: 32345477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity.
    Chang YS; Han JI; Yoo SJ; Lew YJ; Kim JH
    Korean J Ophthalmol; 2014 Dec; 28(6):466-72. PubMed ID: 25435749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
    Krishnan R; Arora R; De Salvo G; Stinghe A; Severn PS; Pal B; Goverdhan S
    Retina; 2015 Sep; 35(9):1750-6. PubMed ID: 26237240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Changes in Retinal Nerve Fiber Layer Thickness after Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
    Jo YJ; Kim WJ; Shin IH; Kim JY
    Korean J Ophthalmol; 2016 Apr; 30(2):114-20. PubMed ID: 27051259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Boiko EV; Maltsev DS
    Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa.
    Yamamoto M; Matsuyama T; Maeda T; Takagi S; Motozawa N; Sakai D; Hirami Y; Maeda A; Kurimoto Y; Takahashi M; Mandai M
    Ophthalmol Sci; 2023 Dec; 3(4):100328. PubMed ID: 37920419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.
    Starr MR; Kung FF; Mejia CA; Bui YT; Bakri SJ
    Retina; 2020 Sep; 40(9):1665-1672. PubMed ID: 31725524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema.
    Zehetner C; Kirchmair R; Huber S; Kralinger MT; Kieselbach GF
    Br J Ophthalmol; 2013 Apr; 97(4):454-9. PubMed ID: 23385630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 Eyes.
    Ciulla TA; Hussain RM; Pollack JS; Williams DF
    Ophthalmol Retina; 2020 Jan; 4(1):19-30. PubMed ID: 31324588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization.
    Kim JH; Chang YS; Kim JW; Kim CG; Yoo SJ; Cho HJ
    Ophthalmology; 2014 Apr; 121(4):926-35. PubMed ID: 24342019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Alternate Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor and Steroid for Treatment-Naive Diabetic Macular Edema in a Real-Life Setting.
    Lee JY; Lee SY; Kim JY; Lee HJ; Jeong JH; Ma DJ
    J Ocul Pharmacol Ther; 2020 Sep; 36(7):555-562. PubMed ID: 32397788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.